title: Anxiety and alcohol use disorders: comorbidity and treatment considerations.
abstract: The co-occurrence of anxiety disorders and alcohol use disorders (AUDs) is relatively common and is associated with a complex clinical presentation. Sound diagnosis and treatment planning requires that clinicians have an integrated understanding of the developmental pathways and course of this comorbidity. Moreover, standard interventions for anxiety disorders or AUDs may need to be modified and combined in targeted ways to accommodate the unique needs of people who have both disorders. Optimal combination of evidence-based treatments should be based on a comparative balance that considers the advantages and disadvantages of sequential, parallel, and integrated approaches.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
authors.forename: Joshua P
authors.initials: JP
authors.lastname: Smith
authors.forename: Carrie L
authors.initials: CL
authors.lastname: Randall
mesh_terms: D000427:Alcohol Deterrents / Q000627:therapeutic use; D019973:Alcohol-Related Disorders / Q000453:epidemiology / Q000523:psychology* / Q000628:therapy; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000453:epidemiology / Q000523:psychology* / Q000628:therapy; D001569:Benzodiazepines / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D015897:Comorbidity; D006801:Humans; D008960:Models, Psychological; D009771:Obsessive-Compulsive Disorder / Q000453:epidemiology / Q000523:psychology / Q000628:therapy; D016584:Panic Disorder / Q000453:epidemiology / Q000523:psychology / Q000628:therapy; D010698:Phobic Disorders / Q000453:epidemiology / Q000523:psychology / Q000628:therapy; D015995:Prevalence; D012651:Self Medication; D012737:Sex Factors; D014481:United States / Q000453:epidemiology
chemical_list: D000427:Alcohol Deterrents; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D001569:Benzodiazepines